About Revive Therapeutics (CVE:RVV)
Revive Therapeutics Ltd. focuses on the development and commercialization of various drugs in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-003, a tianeptine for treatment of Rett Syndrome; and REV-004, a bucillamine for the treatment of cystinurial, as well as REV-005 for the treatment of Wilsons disease, which are under various stages of development. Revive Therapeutics Ltd. Revive Therapeutics Ltd. has a research agreement with the University of Wisconsin-Madison to evaluate a drug delivery technology with a focus on cannabinoids for the treatment of various diseases, such as pain and inflammation for the medical marijuana and pharmaceutical markets in Canada and the United States. It also has a research collaboration with Sanyal Biotechnology LLC to focus on advancing cannabinoids for the treatment of liver diseases. The company is based in Vaughan, Canada.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-117.56%
Return on Assets-101.29%
Revive Therapeutics (CVE:RVV) Frequently Asked Questions
What is Revive Therapeutics' stock symbol?
Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."
When will Revive Therapeutics make its next earnings announcement?
Who are some of Revive Therapeutics' key competitors?
Some companies that are related to Revive Therapeutics include Avante Logixx (XX), Aveda Transportation and Energy Services (AVE), Sterling Resources (SLG), Abcourt Mines (ABI), Energold Drilling (EGD), Crown Point Energy (CWV), Alderon Iron Ore (ADV), Hyperion Exploration (HYX), Oceanic Iron Ore (FEO), Champion Bear Resources (CBA), New Zealand Energy (NZ), North American Tungsten (NTC), Pinecrest Energy (PRY), Porto Energy (PEC), Arcan Resources (ARN), Canamax Energy (CAC), Canopy Growth (CGC) and Ceiba Energy Services (CEB).
Who are Revive Therapeutics' key executives?
Revive Therapeutics' management team includes the folowing people:
- Craig Leon, Chairman of the Board, Chief Executive Officer
- Fabio Chianelli, President, Director
- Carmelo Marrelli, Chief Financial Officer, Secretary
- Robbie Grossman, Director (Age 40)
- Scott Johnson, Director (Age 36)
- Anton Konovalov, Director (Age 26)
- Reiza Rayman M.D., Director (Age 53)
- Carlo Sansalone, Director (Age 35)
How do I buy Revive Therapeutics stock?
Shares of Revive Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Revive Therapeutics' stock price today?
One share of Revive Therapeutics stock can currently be purchased for approximately C$0.26.
How big of a company is Revive Therapeutics?
Revive Therapeutics has a market capitalization of C$15.50 million.
How can I contact Revive Therapeutics?
Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.
MarketBeat Community Rating for Revive Therapeutics (RVV)MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Revive Therapeutics (CVE:RVV) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Revive Therapeutics (CVE:RVV)
No earnings announcements for this company have been tracked by MarketBeat.com
Revive Therapeutics (CVE:RVV) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Revive Therapeutics (CVE:RVV)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Revive Therapeutics (CVE RVV)
No insider trades for this company have been tracked by MarketBeat.com
Revive Therapeutics (CVE RVV) News Headlines
Revive Therapeutics (CVE:RVV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Revive Therapeutics (CVE RVV) Stock Chart for Friday, December, 15, 2017